1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Crestchem Limited

Crestchem Limited

CRSTCHM.BO
Crestchem LimitedIN flagBombay Stock Exchange
127.00
INR
- -
- -
381.00MMarket Cap

Total Valuation

Crestchem Limited carries a market capitalization of 381.00M, placing it among publicly traded companies globally. Its enterprise value stands at 229.51M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap381.00M
Enterprise Value229.51M

Share Statistics

Crestchem Limited currently has 3.00M shares outstanding.

Shares Outstanding3.00M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Crestchem Limited trades at a trailing price-to-earnings ratio of 8.60. The price-to-sales ratio is 0.79, and the price-to-book ratio stands at 7.78.

PE Ratio8.60
PS Ratio0.79
PB Ratio7.78
P/TBV Ratio2.35
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Crestchem Limited trades at an EV/EBITDA multiple of 7.38 and an EV/FCF ratio of 3,242.92. The EV/Sales ratio of 0.78 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 7.38 provides insight into valuation relative to core operating earnings.

EV / Sales0.78
EV / EBITDA7.38
EV / EBIT7.38
EV / FCF3,242.92

Financial Position

Crestchem Limited maintains a current ratio of 0.90, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.

Current Ratio0.90
Quick Ratio0.06
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage317.32

Financial Efficiency

Crestchem Limited posts a return on equity of 51.80 and a return on invested capital of 25.72.

Return on Equity (ROE)51.80
Return on Assets (ROA)20.26
Return on Invested Capital (ROIC)25.72
Return on Capital Employed (ROCE)51.82
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover38,510.64

Taxes

Over the trailing twelve months, Crestchem Limited has paid 10.44M in income taxes, reflecting an effective tax rate of 27.78.

Income Tax10.44M
Effective Tax Rate27.78

Stock Price Statistics

Crestchem Limited's stock has declined approximately -24.60671% over the past 52 weeks. The 50-day moving average sits at 130.24, while the 200-day moving average is 113.34.

Beta (5Y)N/A
52-Week Price Change-24.60671%
50-Day Moving Average130.24
200-Day Moving Average113.34
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Crestchem Limited generated 296.08M in revenue and converted that into 27.14M in net income, yielding earnings per share of 9.05. EBITDA reached 31.10M, while operating income came in at 31.10M.

Revenue296.08M
Gross Profit65.38M
Operating Income31.10M
Pretax Income37.58M
Net Income27.14M
EBITDA31.10M
EBIT31.10M
Earnings Per Share (EPS)9.05

Balance Sheet

Total book value stands at 30.00M, with working capital of -6.18M providing operational flexibility.

Cash & Cash Equivalents4.05M
Total DebtN/A
Net Debt-4.05M
Equity (Book Value)30.00M
Book Value Per Share10.00
Working Capital-6.18M

Margins

Crestchem Limited operates with a gross margin of 22.08, reflecting its pricing power and cost economics. The operating margin of 10.50 and net profit margin of 9.16 provide insight into operational efficiency.

Gross Margin22.08
Operating Margin10.50
Pretax Margin12.69
Profit Margin9.16
EBITDA Margin10.50

Scores

Crestchem Limited posts an Altman Z-Score of 4.62, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.62